Molecular Dynamic Stability Study of VEGF Inhibitor in Patients with Bladder Cancer.
Brolucizumab exhibits inhibitory and blocking activity against VEGFR2, suggesting its potential as a therapeutic agent in bladder cancer.
Authors
- Gerhard Reinaldi Situmorang (ORCID: https://orcid.org/0000-0002-3614-6779)
- Raden Yohana
- Ferry Safriadi (ORCID: https://orcid.org/0000-0002-1685-0064)
- Astrid Feinisa Khairani (ORCID: https://orcid.org/0000-0001-7242-4791)
- Ida Parwati (ORCID: https://orcid.org/0000-0002-9700-589X)
- Ginanda Putra Siregar (ORCID: https://orcid.org/0000-0001-8991-9707)
- Tjahjodjati Tjahjodjati
Institutions
- Universitas Sumatera Utara (ID)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5455/aim.2024.33.50-53
- Citations
- 1
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81